These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3802709)

  • 1. Pharmacokinetics and depressor effect of delapril in patients with essential hypertension.
    Shionoiri H; Yasuda G; Ikeda A; Ohta T; Miyajima E; Kaneko Y
    Clin Pharmacol Ther; 1987 Jan; 41(1):74-9. PubMed ID: 3802709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and acute effect on the renin-angiotensin system of delapril in patients with chronic renal failure.
    Shionoiri H; Yasuda G; Abe Y; Yoshimura H; Kaneko Y; Shindo Y
    Clin Nephrol; 1987 Feb; 27(2):65-70. PubMed ID: 3030595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.
    Minamisawa K; Shionoiri H; Sugimoto K; Ueda S; Ashino K; Ebina T; Gotoh E; Ishii M
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1417-23. PubMed ID: 2177631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Razzetti R; Acerbi D
    Am J Cardiol; 1995 Jun; 75(18):7F-12F. PubMed ID: 7778536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
    Nishiyama K; Igari T; Nanba S; Ishii M
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of delapril in hypertensive patients along the cardiovascular continuum.
    González-Juanatey JR; Cordero A
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):271-81. PubMed ID: 23469905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Mugellini A; Vaccarella A; Celentano A; Scanferla F; Zoppi A; Fogari R
    Blood Press Suppl; 2005 Jul; 1():6-13. PubMed ID: 16060411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
    Stockis A; De Bruyn S; Gengler C; Goethals F; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(8):554-61. PubMed ID: 13677245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers.
    Hutt V; Pabst G; Dilger C; Poli G; Acerbi D
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):59-69. PubMed ID: 7957454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a new angiotensin converting enzyme inhibitor: delapril.
    Saruta T; Nishikawa K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):23S-28S. PubMed ID: 2009144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the effects of delapril, a new angiotensin converting enzyme inhibitor, on the diurnal variation of arterial pressure in patients with essential hypertension using indirect and direct arterial pressure monitoring methods.
    Miyakawa T; Minamisawa K; Yamada Y; Sasaki O; Fujiki Y; Tochikubo O; Ishii M
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):29S-37S. PubMed ID: 2009145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.
    Ogihara T; Kaneko Y; Ikeda M; Yamada K; Omae T; Arakawa K; Ishii M; Yoshinaga K; Kumahara Y; Kokubu T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):42S-45S. PubMed ID: 2009147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single oral dose pharmacokinetic interaction study of manidipine and delapril in healthy volunteers.
    Stockis A; Gengler C; Goethals F; Jeanbaptiste B; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(9):627-34. PubMed ID: 14558436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up.
    Saku K; Zhang B; Hirata K; Liu R; Sasaki N; Sakai T; Ying H; Arakawa K
    Clin Ther; 1992; 14(6):813-20. PubMed ID: 1286488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat.
    Morishita R; Higaki J; Nakamura F; Tomita N; Yu H; Nagano M; Mikami H; Ogihara T
    Blood Press Suppl; 1992; 3():41-7. PubMed ID: 1343288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.